Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Saturday, March 24, 2012

Friday, April 27, 2012  live-streamed webinar featuring patient inclusion #HITTMIT
Patient Safety and High Performance Leadership in Health Information Technology Summit

The Patient Panel - by Regina Holliday

No comments:

Post a Comment